Our Story

Discover the story behind Metabolomycs, Inc. and our dedication to advancing metabolomics research. Our journey began with a vision to make meaningful contributions to scientific discovery and healthcare innovation.

As a team, we are driven by the desire to unravel the complexities of metabolics and translate our findings into tangible benefits for society. With a focus on cutting-edge technology and interdisciplinary collaboration, we strive to differentiate ourselves and lead the way in metabolomics research and development.

Experienced Leadership

At Metabolomycs, Inc., our experienced leadership team brings together expertise from diverse scientific disciplines, enabling us to pursue comprehensive and impactful research in metabolomics.

We are dedicated to fostering a culture of excellence and creativity, empowering our team to push the boundaries of scientific exploration. With a shared commitment to driving positive change through metabolomics, we aim to establish Metabolomycs, Inc. as a prominent force in the research community.

Meet Our Experienced Team of Medical & Business Professionals

Under the leadership of Dr. Robert Nagourney, our team has amassed decades of experience in Oncology, Hematology, Molecular biology, Metabolomics and Mass spectrometry.

Dr N cropped in lab

Robert Nagourney, MD

Founder

Founder, CEO of Nagourney Cancer Institute Internationally recognized for his pioneering work in human phenotypic analysis Read More
ismael-dale-cotrim-da-silva

Ismael Dale Cotrim da Silva, MD, PhD

Co-Founder

Senior Advisor and Coordinator of Molecular Biology at Fleury Laboratories. Holds several international patents in cancer and non-malignant diseases. Read More
Paulo D'Amora, MD, PhD

Paulo D'Amora, MD, PhD

Research Director

Award-winning researcher from Sao Paulo State Research Foundation; Directs research on NextGen Metabolomics between US and Brazil research centers. Read More
Steve Evans

Steven Evans, BS, MA

Lab Director

COO, Nagourney Cancer Institute, Former Senior Research Scientist at Todd Cancer Institute in Long Beach, CA Read More
Rhoderic Bannatyne

Rhoderic Bannatyne

Chief Financial Officer

CFO - Vidimetrics Ltd, Caliper; Auditor with KPMG UK; experience with SaaS & Biotech ventures in Europe & US. Read More
Glenn Bernstein

Glenn Bernstein, MBA

Director - Marketing & Business Development

Glenn Bernstein, MBA - Marketing Director at Nagourney Cancer Institute, former Regional Sales Mgr. at American Home Shield, Business Strategist improving companies throughout US, Canada. Read More
Dr N cropped in lab
Founder

Robert Nagourney, MD

Founder, CEO of Nagourney Cancer Institute Internationally recognized for his pioneering work in human phenotypic analysis

ismael-dale-cotrim-da-silva
Co-Founder

Ismael Dale Cotrim da Silva, MD, PhD

Senior Advisor and Coordinator of Molecular Biology at Fleury Laboratories. Holds several international patents in cancer and non-malignant diseases.

Paulo D'Amora, MD, PhD
Research Director

Paulo D'Amora, MD, PhD

Award-winning researcher from Sao Paulo State Research Foundation; Directs research on NextGen Metabolomics between US and Brazil research centers.

Steve Evans
Lab Director

Steven Evans, BS, MA

COO,  Nagourney Cancer Institute, Former Senior Research Scientist at Todd Cancer Institute in Long Beach, CA

Rhoderic Bannatyne
Chief Financial Officer

Rhoderic Bannatyne

CFO - Vidimetrics Ltd, Caliper; Auditor with KPMG UK; experience with SaaS & Biotech ventures in Europe & US.

Glenn Bernstein
Director - Marketing & Business Development

Glenn Bernstein, MBA

Glenn Bernstein, MBA - Marketing Director at Nagourney Cancer Institute, former Regional Sales Mgr. at American Home Shield, Business Strategist improving companies throughout US, Canada.